NCT06787911 2025-01-22
Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
Fudan University
Phase 2 Recruiting
Clinical Trials
18 trialsNCT06680115 2024-11-08
Neoadjuvant and Adjuvant Sintilimab Combined with Chemoradiotherapy Versus Chemoradiotherapy Alone in Stage TanyN3M0 Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 2 Not yet recruiting
NCT04718415 2024-09-19
OOC-001
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Active not recruiting
NCT06364826 2024-04-15
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Not yet recruiting
NCT05098119 2024-03-26
Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT06240689 2024-02-05
A Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT04072107 2023-06-18
EP-STAR
Sun Yat-sen University
Phase 2 Unknown
NCT05749042 2023-03-01
A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma
China Three Gorges University, Yichang, China
Phase 2 Unknown
NCT04872582 2023-02-23
Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study
Sun Yat-sen University
Phase 2 Unknown
NCT05000892 2022-12-02
Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT05201859 2022-05-06
Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown
NCT05136768 2021-11-29
LM-HNSCC
ChineseAMS
Phase 2 Unknown
NCT04917770 2021-06-08
The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
West China Hospital
Phase 2 Unknown
NCT04882462 2021-05-12
Carpp-1
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT04769076 2021-02-25
The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
NCT04065737 2019-08-22
STOP
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT03975270 2019-07-18
HNSCC
ChineseAMS
Phase 2 Unknown
NCT03619824 2018-10-09
PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown